QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD
QIPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of QIPT have multiple concerns. QIPT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIPT has reported negative net income.
In the past year QIPT had a positive cash flow from operations.
In the past 5 years QIPT reported 4 times negative net income.
QIPT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QIPT has a Return On Assets (-2.99%) which is comparable to the rest of the industry.
QIPT has a Return On Equity (-6.83%) which is comparable to the rest of the industry.
The Return On Invested Capital of QIPT (0.14%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for QIPT is significantly below the industry average of 9.59%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROIC | 0.14% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
1.3 Margins
QIPT has a Operating Margin of 0.14%. This is comparable to the rest of the industry: QIPT outperforms 40.20% of its industry peers.
QIPT's Gross Margin of 71.56% is amongst the best of the industry. QIPT outperforms 90.20% of its industry peers.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
QIPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
QIPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, QIPT has more shares outstanding
QIPT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.44, we must say that QIPT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.44, QIPT is not doing good in the industry: 75.49% of the companies in the same industry are doing better.
The Debt to FCF ratio of QIPT is 4.91, which is a neutral value as it means it would take QIPT, 4.91 years of fcf income to pay off all of its debts.
QIPT has a better Debt to FCF ratio (4.91) than 66.67% of its industry peers.
QIPT has a Debt/Equity ratio of 0.74. This is a neutral value indicating QIPT is somewhat dependend on debt financing.
QIPT has a Debt to Equity ratio (0.74) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Altman-Z | 0.44 |
ROIC/WACC0.02
WACC7.41%
2.3 Liquidity
A Current Ratio of 1.22 indicates that QIPT should not have too much problems paying its short term obligations.
The Current ratio of QIPT (1.22) is worse than 60.78% of its industry peers.
QIPT has a Quick Ratio of 1.22. This is a bad value and indicates that QIPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QIPT has a worse Quick ratio (0.87) than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -80.00%.
The Revenue has grown by 10.92% in the past year. This is quite good.
The Revenue has been growing by 32.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-10.29%
3.2 Future
Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 97.77% on average per year.
The Revenue is expected to grow by 21.85% on average over the next years. This is a very strong growth
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Also next year QIPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
97.06% of the companies in the same industry are more expensive than QIPT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QIPT is valued cheaply inside the industry as 96.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.2 | ||
| EV/EBITDA | 3.87 |
4.3 Compensation for Growth
A more expensive valuation may be justified as QIPT's earnings are expected to grow with 16.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.9%
EPS Next 3Y16.35%
5. Dividend
5.1 Amount
No dividends for QIPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2
+0.07 (+3.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.95%
Inst Owner Change6.51%
Ins Owners9.53%
Ins Owner Change54.32%
Market Cap86.18M
Analysts82.22
Price Target6.44 (222%)
Short Float %4.51%
Short Ratio1.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.98%
Min EPS beat(2)-124.09%
Max EPS beat(2)32.12%
EPS beat(4)1
Avg EPS beat(4)-255.78%
Min EPS beat(4)-540.96%
Max EPS beat(4)32.12%
EPS beat(8)1
Avg EPS beat(8)-522.14%
EPS beat(12)3
Avg EPS beat(12)-242.54%
EPS beat(16)4
Avg EPS beat(16)-226.56%
Revenue beat(2)0
Avg Revenue beat(2)-11.63%
Min Revenue beat(2)-20.53%
Max Revenue beat(2)-2.74%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-2.74%
Revenue beat(8)1
Avg Revenue beat(8)-4.62%
Revenue beat(12)1
Avg Revenue beat(12)-4.57%
Revenue beat(16)2
Avg Revenue beat(16)-4.02%
PT rev (1m)-1.29%
PT rev (3m)-3.48%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)100%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.36 | ||
| P/FCF | 4.2 | ||
| P/OCF | 2.62 | ||
| P/B | 0.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.87 |
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.48
FCFY23.82%
OCF(TTM)0.76
OCFY38.23%
SpS5.61
BVpS2.47
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROCE | 0.18% | ||
| ROIC | 0.14% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.5% | ||
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% | ||
| FCFM | 8.48% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
ROICexc(3y)2.81%
ROICexc(5y)N/A
ROICexgc(3y)9.78%
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Debt/EBITDA | 1.82 | ||
| Cap/Depr | 28.74% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.44 |
F-Score3
WACC7.41%
ROIC/WACC0.02
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-10.29%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
EBIT growth 1Y-93.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1615.9%
EBIT Next 3Y157.9%
EBIT Next 5Y154.85%
FCF growth 1Y23.94%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y26.48%
OCF growth 3Y23.7%
OCF growth 5Y33.42%